Prestige Assurance Plc (NGX:PRESTIGE)
Nigeria · Delayed Price · Currency is NGN 1.260
+0.100 (8.62%)
At close: Aug 1, 2025
CTI BioPharma Cash Flow Statement
Financials in millions NGN. Fiscal year is January - December.
Millions NGN. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 2,879 | 1,310 | 502.26 | 688.28 | 678.31 | Upgrade |
Depreciation & Amortization | 153.78 | 96.91 | 127.87 | 123.76 | 99.72 | Upgrade |
Other Amortization | 9.98 | 7.13 | 6.97 | 4.9 | 5.8 | Upgrade |
Gain (Loss) on Sale of Assets | - | -10.33 | -14.34 | -3.42 | -0.55 | Upgrade |
Gain (Loss) on Sale of Investments | - | -114.4 | 9.7 | -11.82 | -3.25 | Upgrade |
Change in Accounts Receivable | - | -412.47 | -398.22 | 71.01 | -77.56 | Upgrade |
Reinsurance Recoverable | - | -969.82 | -604.13 | -2,673 | -827.24 | Upgrade |
Change in Accounts Payable | - | 52.34 | 34.85 | 37.93 | 4.2 | Upgrade |
Change in Unearned Revenue | - | - | - | 312.54 | 309.47 | Upgrade |
Change in Insurance Reserves / Liabilities | - | 2,487 | 514.61 | 1,939 | 1,005 | Upgrade |
Change in Other Net Operating Assets | - | 165.19 | -176.12 | 304.06 | 1.49 | Upgrade |
Other Operating Activities | -3,901 | -2,031 | -938.55 | -1,063 | -756.39 | Upgrade |
Operating Cash Flow | -858.23 | 848.33 | -1,034 | -404.47 | 443.51 | Upgrade |
Capital Expenditures | -113.08 | -87.83 | -125.41 | -129.88 | -12.76 | Upgrade |
Sale of Property, Plant & Equipment | 1.48 | 11.25 | 14.34 | 5.74 | 0.65 | Upgrade |
Purchase / Sale of Intangible Assets | - | -30.1 | -20.75 | - | - | Upgrade |
Investment in Securities | -2,116 | -2,624 | -578.25 | -391.73 | -298.69 | Upgrade |
Other Investing Activities | 2,128 | 954.6 | 703.9 | 4,136 | -2,709 | Upgrade |
Investing Cash Flow | -313.53 | -1,472 | 329.17 | 3,675 | -3,020 | Upgrade |
Total Debt Repaid | -35.36 | - | -0.21 | -3.27 | -6.4 | Upgrade |
Net Debt Issued (Repaid) | -35.36 | - | -0.21 | -3.27 | -6.4 | Upgrade |
Issuance of Common Stock | - | - | - | - | 3,446 | Upgrade |
Common Dividends Paid | -265.14 | - | -198.79 | -331.32 | - | Upgrade |
Other Financing Activities | -1.71 | - | - | -1.28 | -296.63 | Upgrade |
Financing Cash Flow | -302.21 | - | -199 | -335.86 | 3,143 | Upgrade |
Foreign Exchange Rate Adjustments | - | 55.56 | 19.79 | 7.69 | 15.27 | Upgrade |
Miscellaneous Cash Flow Adjustments | -0 | -0 | - | - | - | Upgrade |
Net Cash Flow | -1,474 | -568.18 | -884.21 | 2,942 | 581.49 | Upgrade |
Free Cash Flow | -971.31 | 760.5 | -1,160 | -534.35 | 430.76 | Upgrade |
Free Cash Flow Margin | -4.16% | 5.30% | -8.75% | -8.30% | 8.70% | Upgrade |
Free Cash Flow Per Share | -0.07 | 0.06 | -0.09 | -0.04 | 0.06 | Upgrade |
Cash Interest Paid | 1.71 | - | 1.73 | 1.28 | 5.71 | Upgrade |
Cash Income Tax Paid | 76.28 | 121.92 | 28.81 | 36.39 | 30.64 | Upgrade |
Levered Free Cash Flow | 3,587 | 1,790 | 678.3 | 3,236 | -1,977 | Upgrade |
Unlevered Free Cash Flow | 3,588 | 1,791 | 679.38 | 3,237 | -1,974 | Upgrade |
Change in Net Working Capital | -2,636 | -1,464 | -389.2 | -2,841 | 2,469 | Upgrade |
Updated Jan 30, 2025. Source: S&P Global Market Intelligence. Insurance template. Financial Sources.